Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 14
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Why be social? The costs and benefits of sociality in spiders

    Sociality in spiders is extremely rare, but it has evolved several times. This begs the question: why be social...

    Barcoding Alaska

    We want to DNA barcode plants of the Alaskan wild with the help of citizen scientists and local Brooklyn...

    Backer Badge Funded